Get the Stockscreener App
23.69
5.28%
-1.32
Centessa Pharmaceuticals Plc Adr stock is traded at $23.69, with a volume of 783.71K.
It is down -5.28% in the last 24 hours and down -16.91% over the past month.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
See More
Previous Close:
$25.01
Open:
$24.88
24h Volume:
783.71K
Relative Volume:
0.53
Market Cap:
$3.50B
Revenue:
-
Net Income/Loss:
$-151.09M
P/E Ratio:
-15.19
EPS:
-1.56
Net Cash Flow:
$-160.51M
1W Performance:
-6.47%
1M Performance:
-16.91%
6M Performance:
+72.42%
1Y Performance:
+35.37%
1-Day Range:
$23.49
$25.21
1-Week Range:
$23.49
$25.70
52-Week Range:
$9.60
$30.58
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Name
Centessa Pharmaceuticals Plc Adr
Sector
Industry
Phone
44 7391 789784
Address
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
23.69 | 3.70B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Resumed | Oppenheimer | Outperform |
| Oct-28-25 | Initiated | Stephens | Overweight |
| Sep-03-25 | Initiated | Wells Fargo | Overweight |
| Aug-29-25 | Resumed | Oppenheimer | Outperform |
| Jul-21-25 | Initiated | Truist | Buy |
| May-28-25 | Initiated | Needham | Buy |
| May-08-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
| Sep-20-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Jul-18-24 | Initiated | Oppenheimer | Outperform |
| Nov-15-23 | Upgrade | Jefferies | Hold → Buy |
| Oct-26-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jun-21-23 | Initiated | Evercore ISI | Outperform |
| Jun-12-23 | Initiated | Guggenheim | Buy |
| Mar-17-23 | Initiated | SVB Securities | Outperform |
| Aug-12-22 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-03-22 | Downgrade | Jefferies | Buy → Hold |
| Feb-11-22 | Initiated | Goldman | Neutral |
View All
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Latest News
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap DownHere's What Happened - MarketBeat
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
oracle, visa among market cap stock movers on thursday By Investing.com - Investing.com UK
oracle, visa among market cap stock movers on thursday - Investing.com India
Russell Investments Group Ltd. Has $1.85 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa stock falls on CEO transition announcement By Investing.com - Investing.com South Africa
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - setenews.com
Stempoint Capital LP Increases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Accardi sells Centessa (CNTA) shares worth $288,288 - Investing.com
Centessa Pharma president sells shares for $300,000 By Investing.com - Investing.com South Africa
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results - Finviz
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 10,000 Shares of Stock - MarketBeat
Centessa Pharma president sells shares for $300,000 - Investing.com India
100,362 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Purchased by Bollard Group LLC - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighStill a Buy? - MarketBeat
Affinity Asset Advisors LLC Sells 646,500 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD - Investing.com
Saturn V Capital Management LP Acquires 344,635 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
B. Riley Research Analysts Raise Earnings Estimates for CNTA - MarketBeat
OMERS ADMINISTRATION Corp Buys New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
B. Riley Analysts Boost Earnings Estimates for CNTA - Defense World
Centessa Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:CNTA) - MarketBeat
Healthy Upside Potential: Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
What is Palisade Bio Inc (PALI) Stock Return on Shareholders’ Capital? - setenews.com
Grupo Supervielle S.A. ADR (SUPV) looking to reclaim success with recent performance - Setenews
The growth track for Tron Inc (TRON) has changed recently - Setenews
Taking the lead: Argo Blockchain Plc ADR (ARBK) - Setenews
Check out these key findings about Polestar Automotive Holding UK PLC ADR (PSNY) - Setenews
There is no way Rezolve AI PLC (RZLV) can keep these numbers up - Setenews
Check out these key findings about Nova Minerals Limited ADR (NVA) - Setenews
Check Out INVO Fertility Inc (IVF)’s Trade Data Rather Than the Analysts’ Views - Setenews
An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews
Meridian Wealth Partners LLC Invests $501,000 in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Stocks of Klarna Group plc (KLAR) are poised to climb above their peers - Setenews
Its Stock Has Paid Off Big Time For Aptera Motors Corp - Setenews
It makes sense and dollars to buy ATA Creativity Global ADR (AACG) stock - Setenews
Check out these key findings about Hub Cyber Security Ltd (HUBC) - Setenews
A better buy-in window may exist right now for Centessa Pharmaceuticals plc ADR (CNTA) - Setenews
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Views of Wall Street’s Leading Experts on Liminatus Pharma Inc - Setenews
Investors in cash trouble should check out Bonk Inc (BNKK) - Setenews
Centessa (CNTA) launches $250M ATM ADS offering via Leerink - Stock Titan
Brokers Set Expectations for CNTA FY2025 Earnings - Defense World
Prepare Yourself for Liftoff: Seadrill Ltd (SDRL) - setenews.com
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.31 USD - Investing.com
Stevanato Group Spa (STVN) looking to reclaim success with recent performance - setenews.com
CNTA: Phase 2 data show best-in-class efficacy and safety for orexin agonists in sleep disorders - TradingView
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):